Coriolis Pharma: Your Collaborative Partner from Preclinical to Market Success

Sylvia Steyrer-Gruber, CEO, Johannes Clemens, CCO, and Dr. Andrea Hawe, CSO, share how Coriolis Pharma and its end-to-end services accelerate and derisk the entire drug product lifecycle. Anticipating and mitigating risks, coupled with the experience required to accelerate development, has led to the completion of successful projects with over 800 biopharmaceutical customers worldwide.